R57.0 R57.1 R57.2 R57.8 R57.9
Conditions
Interventions
Group 1: (1.) Ventilated adult patients with shock (n=50) and (2.) ventilated adult patients with shock and ECMO (extracorporeal membrane oxygenation) therapy (n=25) should receive cutaneous HSI (hype
Sponsors
Klinik für Anästhesiologie und IntensivmedizinUniversitätsklinikum Essen
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Written declaration of consent by the legal representative - Inclusion according to the regulations of the consiliary physician procedure - age > 18 years - shock of any origin - invasive ventilation
Exclusion criteria
Exclusion criteria: - Age < 18 years - Refusal to participate in the study - Patient likely to be transferred from ICU within first 72 hours of study inclusion - Palliative therapeutic approach - Existing therapy goal limitation - Death of the patient is already foreseeable or inevitable at study inclusion - Dark skin type (methodological limitation for cutaneous hyperspectral imaging)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measures are the correlations of the HSI parameters (StO2, NIR, or NPI, THI, and TWI) with the vasoactive-inotropic score (VIS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary objective is to investigate the relationship between HSI data and severity of organ dysfunction using the sepsis-related organ failure assessment score (SOFA score), macrocirculatory paramaters, and established clinical parameters for systemic oxygen supply deficit include (e.g., blood lactate levels). | — |
Countries
Germany
Contacts
Public ContactKarsten Schmidt
Klinik für Anästhesiologie und IntensivmedizinUniversitätsklinikum Essen
Outcome results
None listed